An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...

From his perspective, one of the most persistent misconceptions in prostate cancer care relates to how patients interpret ...

ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced the presentation of ...

Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...

In a biopsy, a small sample of tissue is taken from your body. A pathologist analyzes the sample to check for cancer cells. The main method for diagnosing prostate cancer is a core needle biopsy. It’s ...

New research indicates that psychosocial factors—which influence how a person perceives, interprets, and reacts to their surroundings—do not affect an individual's risk of developing cancer. The ...

Northwestern Medicine scientists have uncovered an unexpected role for a well-known cancer-related protein, revealing a new ...

When prostate cancer has spread beyond the prostate to nearby lymph nodes and other areas of the body and treatments can no longer slow or stop its growth, you are not alone. Many patients, despite ...

Research from investigators at Rutgers Cancer Institute of New Jersey and the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, shows the intracellular process of ...

A common diabetes medication could help men with prostate cancer who develop hormone therapy-related metabolic syndrome through a biological process closely associated with exercise.An evaluation of ...

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...